Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
Monoclonal antibodies (MAbs) were obtained by immunizing mice with synthetic peptides corresponding to the third variable (V3) or the third conserved (C3) domain of the external envelope protein (gp120) of human immunodeficiency virus type 2 (HIV-2ROD). One MAb, designated B2C, which was raised agai...
Kaydedildi:
| Yayımlandı: | J Virol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1995
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7538171/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.6.3333-3340.1995 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|